Rho-kinase inhibitor alleviates CD4+T cell mediated corneal graft rejection by modulating its STAT3 and STAT5 activation.
Exp Eye Res
; 242: 109857, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38479724
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
CD4-Positive T-Lymphocytes
/
STAT3 Transcription Factor
/
STAT5 Transcription Factor
/
Rho-Associated Kinases
/
Amides
/
Graft Rejection
/
Mice, Inbred BALB C
/
Mice, Inbred C57BL
Limits:
Animals
Language:
En
Journal:
Exp Eye Res
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido